TACTILE SYSTEMS TECHNOLOGY,INC. (NASDAQ:TCMD) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote
of Security Holders
On May9, 2017, Tactile Systems Technology,Inc. (the Company) held
its 2017 Annual Meeting of Stockholders and the Companys
stockholders voted on the following matters:
Election of Directors
The following nominees were elected to serve as directors for a
term that will last until the Companys 2018 Annual Meeting of
Stockholders or until their successor is duly elected and
qualified. The number of votes cast for and withheld from each
nominee and the number of broker non-votes with respect to each
nominee were as follows:
|
Name |
|
VotesFor |
|
VotesWithheld |
|
BrokerNon-Votes |
|
William W. Burke |
10,584,323 |
264,229 |
3,306,644 |
|||
|
Jordan S. Davis |
9,126,826 |
1,721,726 |
3,306,644 |
|||
|
Gerald R. Mattys |
10,637,859 |
210,693 |
3,306,644 |
|||
|
Richard J. Nigon |
9,184,093 |
1,664,459 |
3,306,644 |
|||
|
Kevin H. Roche |
10,584,223 |
264,329 |
3,306,644 |
|||
|
Peter H. Soderberg |
9,178,176 |
1,670,376 |
3,306,644 |
Ratification of the Selection of Grant Thornton LLP as the
Companys Independent Auditor for 2017
The Companys stockholders ratified the appointment by the Audit
Committee of the Companys Board of Directors of Grant Thornton
LLP as the Companys independent registered public accounting firm
for the year ending December31, 2017 by voting as follows:
|
For |
|
Against |
|
Abstain |
|
BrokerNon-Votes |
|
|
14,146,901 |
4,428 |
3,867 |
|
About TACTILE SYSTEMS TECHNOLOGY, INC. (NASDAQ:TCMD)
Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency. Its products deliver long-term treatment of chronic diseases. The Company provides its products for use in the home and sells them through vascular, wound and lymphedema clinics throughout the United States. The Company offers a platform to deliver at-home healthcare solutions throughout the United States. Its initial area of therapeutic focus is vascular disease, with a focus on advancing the care in treating lymphedema and chronic venous insufficiency. TACTILE SYSTEMS TECHNOLOGY, INC. (NASDAQ:TCMD) Recent Trading Information
TACTILE SYSTEMS TECHNOLOGY, INC. (NASDAQ:TCMD) closed its last trading session down -0.25 at 21.60 with 186,792 shares trading hands.
